Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 69 publications
Efficacy and Safety of Ligelizumab in Individuals With Confirmed Peanut Allergy.
Journal: Allergy
Published: June 10, 2025
Dupilumab efficacy in subgroups of type 2 asthma with high-dose inhaled corticosteroids at baseline.
Dupilumab efficacy in subgroups of type 2 asthma with high-dose inhaled corticosteroids at baseline.
Journal: Respiratory medicine
Published: March 17, 2022
Efficacy of dupilumab in patients with uncontrolled, moderate-to-severe asthma recruited from Japanese centers in the phase 3 LIBERTY ASTHMA TRAVERSE study.
Journal: Allergology international : official journal of the Japanese Society of Allergology
Published: January 07, 2022
Clinical Efficacy among Patients with Chronic Rhinosinusitis with Nasal Polyps and Clinical Features of Obstructive Lung Disease: Post Hoc Analysis of the Phase III SINUS-24 and SINUS-52 Studies.
Journal: Journal of asthma and allergy
Published: January 07, 2022
Improvement in Lung Function with Dupilumab Does Not Predict Its Effects on Reducing Asthma Exacerbation.
Journal: Journal of asthma and allergy
Published: December 21, 2021
Effect of Dupilumab on Blood Eosinophil Counts in Patients With Asthma, Chronic Rhinosinusitis With Nasal Polyps, Atopic Dermatitis, or Eosinophilic Esophagitis.
Journal: The journal of allergy and clinical immunology. In practice
Published: November 12, 2021
Dupilumab Efficacy in Patients With Uncontrolled or Oral Corticosteroid-Dependent Allergic and Nonallergic Asthma.
Journal: The journal of allergy and clinical immunology. In practice
Published: October 11, 2021
Dupilumab Is Effective in Patients With Moderate-to-Severe Uncontrolled GINA-Defined Type 2 Asthma Irrespective of an Allergic Asthma Phenotype.
Journal: The journal of allergy and clinical immunology. In practice
Published: September 30, 2021
Dupilumab efficacy and safety in patients with asthma and blood eosinophils ≥500 cells·µL-1.
Journal: The European respiratory journal
Published: September 27, 2021
Dupilumab Efficacy in Steroid-Dependent Severe Asthma by Baseline Oral Corticosteroid Dose.
Journal: The journal of allergy and clinical immunology. In practice
Published: September 23, 2021
Respiratory Infections and Anti-Infective Medication Use From Phase 3 Dupilumab Respiratory Studies.
Respiratory Infections and Anti-Infective Medication Use From Phase 3 Dupilumab Respiratory Studies.
Journal: The journal of allergy and clinical immunology. In practice
Published: September 17, 2021
Last Updated: 09/26/2026